Financials
Financial year 2025
Taikun Pharmaceutical Technology from Gent, company number BE1007641938, closed financial year 2025 with a result of € -161,100 after tax. For that financial year Taikun Pharmaceutical Technology recorded a gross margin of € -158,581 and equity of € 138,900. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 20, 2026.
€ 138,900
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -161,100
Profit after tax over the fiscal year.
€ 200,754
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -161,100.
Debts at end 2025
€ 101,310
Loans from banks and other lenders, long and short.
€ 75
Supplier invoices still open on the last day of the fiscal year.
What happened to Taikun Pharmaceutical Technology?
What happened at Taikun Pharmaceutical Technology in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 161,100. Source: NBB ↗
- New establishment in Wevelgem. KBO
- New establishment in Gent. KBO
- Tom De Gres became a director. NBB
- Jun Ji became a director. NBB
- Yuzhu Feng became a director. NBB
- Zhennyu Shi became a director. NBB
- Hubert Sigiez became a director. NBB
Management
The stake of United NRJ, Ace comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Taikun Pharmaceutical TechnologyBehind Taikun Pharmaceutical Technology are Tom De Gres, Jun Ji, Yuzhu Feng, Zhennyu Shi and Hubert Sigiez. The shares are held by United NRJ (15%) and Ace (15%).
Directors
According to the 2025 annual accounts
Tom De Gres
Director
Also active at: Ace, SAVERDE, SOLVUS, International Platform for Art Research & Conservation, FoodCheck
since 2024
Jun Ji
Director
since 2024
Yuzhu Feng
Director
since 2024
Zhennyu Shi
Director
since 2024
Hubert Sigiez
Director
since 2024
Shareholders
15%
15%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Frieda Saeysstraat 3
9052 Gent
Vliegveld 13
8560 Wevelgem
Active since 27 April 2026
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1007.641.938
- VAT number
- BE 1007.641.938
- Registered office
- Frieda Saeysstraat 3, 9052 Gent
- Names & denominations
- Taikun Pharmaceutical Technology
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 27 March 2024
- Peppol
- Active · Active since 21 Oct 2026
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Vervaardiging van farmaceutische grondstoffen
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied